XBIT
XBiotech Inc.
0.00 (0.00%)2.15USD23.8K成交股數65.5M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | 0 | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | 0 | 0 |
| 毛利 | – | – | – | – | – | – | – | – | – | – | 0 | 0 |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.3M | 5.2M | 25.4M | 5.1M | 5.3M | 11.6M | 7.1M | 13.0M | 9.8M | – | 7.5M | 11.3M |
| 銷售管理費用 | 850K | 1.1M | 4.4M | 967K | 1.0M | 1.9M | 777K | 2.0M | 1.0M | – | 973K | 2.0M |
| 營業利益 | −6.1M-3% | −6.3M-54% | −29.8M+276% | −6.0M-60% | −6.3M-42% | −13.6M+58% | −7.9M-7% | −15.0M+13% | −10.9M | −8.6M | −8.5M | −13.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −6.7M+283% | −5.5M-49% | −26.9M+436% | −6.0M-54% | −1.8M-82% | −10.9M+135% | −5.0M-32% | −13.0M+49% | −10.0M | −4.6M | −7.4M | −8.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | 30.5M | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 110M | 115M | 126M | 147M | 153M | 156M | 183M | 189M | 201M | 200M | 202M | 143M |
| 應收帳款 | – | – | – | 450K | 480K | 480K | 730K | 870K | 870K | 860K | 881K | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 134M | 140M | 150M | 172M | 179M | 182M | 210M | 216M | 228M | 227M | 230M | 235M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 5.2M | 4.8M | 9.7M | 5.3M | 5.6M | 7.2M | 17.7M | 18.9M | 18.6M | 7.8M | 6.9M | 6.1M |
| 股東權益 | 128M | 135M | 140M | 167M | 173M | 175M | 192M | 197M | 209M | 219M | 223M | 229M |
| 負債比 | 3.9% | 3.4% | 6.5% | 3.1% | 3.1% | 3.9% | 8.5% | 8.7% | 8.2% | 3.4% | 3.0% | 2.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.0M+33% | – | – | – | −6.7M | – | – | −7.2M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 94K | – | – | 255K | – | – | – |
| 自由現金流 | – | −9.0M+32% | – | – | – | −6.8M | – | – | −7.5M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 4.0M
| Manufacturing Revenue | 4.0M | 100.0% | -77.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −45.5M | –% | -1.49 | −40.2M |
| FY2024 | – | – | −38.5M | –% | -1.26 | −32.3M |
| FY2023 | 0 | -100.0% | −24.6M | –% | -0.81 | −19.1M |
| FY2022 | 4.0M | -78.2% | −32.9M | -820.4% | -1.08 | −15.4M |
| FY2021 | 18.4M | -58.2% | −17.4M | -94.7% | -0.58 | 65.9M |
| FY2020 | 44.0M | – | −11.2M | -25.5% | -0.36 | −68.9M |
| FY2019 | 0 | – | 669M | –% | 14.44 | −18.5M |
| FY2018 | 0 | – | −21.1M | –% | -0.59 | −16.7M |